Couldn't load this record
The USPTO API returned an error (HTTP 429) — please try again shortly.
Patent Application
Utility
App. No. 18/331,817
· Confirmation No. 4331
ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME
Applicant:
Sumitomo Pharma Oncology, Inc.
Abandoned -- Incomplete Application (Pre-examination)
View Publication ↗
No downloadable documents found — record may not be publicly available.
Inventors
David J. BEARSS
Alpine, UT
Steven L. WARNER
Sandy, UT
Attorneys & Agents of Record
Classification
USPC
424/456
A61K31/506
A61K45/06
A61P7/06
A61P7/00
A61K9/0053
A61K9/4825
A61K9/4866
A61K31/453
A61K31/454
A61K31/519
G01N33/721
G01N2800/52
A61K2300/00
Prosecution
- Art Unit
- 1612
- Customer No.
- 161613
- Docket No.
- 251285-529384
- Confirmation No.
- 4331
Publication
- Pub. No.
- US20240075033A1
- Pub. Date
- 2024-03-07
Parent
is a Continuation of
→
App. 16/740,219
Filed 2020-01-10
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 62/790,961
Filed 2019-01-10
· Provisional Application Expired
Child
is a Continuation of
→
App. 18/496,788
Filed 2023-10-27
· Abandoned -- Incomplete Application (Pre-examination)
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/331,817
- Filed
- 2023-06-08
- Pub. No.
- US20240075033A1
- Art Unit
- 1612
External Links